- 1.
Heath M, Jaimes N, Lemos B et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008; 58: 375–81. [PubMed][CrossRef]
- 2.
Becker JC, Stang A, DeCaprio JA et al. Merkel cell carcinoma. Nat Rev Dis Primers 2017; 3: 17077. [PubMed][CrossRef]
- 3.
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Merkel cell carcinoma. Version 1.2021. https://merkelcell.org/wp-content/uploads/2021/02/NCCN-2021.pdf Lest 20.2.2022.
- 4.
Becker JC, Eigentler T, Frerich B et al. S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018. J Dtsch Dermatol Ges 2019; 17: 562–76. [PubMed][CrossRef]
- 5.
Walsh NM, Cerroni L. Merkel cell carcinoma: A review. J Cutan Pathol 2021; 48: 411–21. [PubMed][CrossRef]
- 6.
Zaar O, Gillstedt M, Lindelöf B et al. Merkel cell carcinoma incidence is increasing in Sweden. J Eur Acad Dermatol Venereol 2016; 30: 1708–13. [PubMed][CrossRef]
- 7.
Paulson KG, Park SY, Vandeven NA et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol 2018; 78: 457–463.e2. [PubMed][CrossRef]
- 8.
Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49: 832–41. [PubMed][CrossRef]
- 9.
Wong SQ, Waldeck K, Vergara IA et al. UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas. Cancer Res 2015; 75: 5228–34. [PubMed][CrossRef]
- 10.
Feng H, Shuda M, Chang Y et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096–100. [PubMed][CrossRef]
- 11.
Becker JC, Houben R, Ugurel S et al. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 2009; 129: 248–50. [PubMed][CrossRef]
- 12.
Arora R, Gupta K, Vijaykumar A et al. DETECTing Merkel cell polyomavirus in Merkel tumors. Front Mol Biosci 2020; 7: 10. [PubMed][CrossRef]
- 13.
Regionala cancercentrum i samverkan. Merkelcellscancer. Nationellt vårdprogram. 31.8.2021, versjon: 1.1. https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/hud/merkelcellscancer/vardprogram/nationellt-vardprogram-merkelcellscancer.pdf Lest 20.2.2022.
- 14.
Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne melanomer. IS-2931. 2020. https://www.helsedirektoratet.no/retningslinjer/maligne-melanomer-handlingsprogram/Nasjonalt%20handlingsprogram%20med%20retningslinjer%20for%20diagnostikk,%20behandling%20og%20oppf%C3%B8lging%20av%20maligne%20melanomer.pdf/ Lest 20.2.2022.
- 15.
Trinidad CM, Torres-Cabala CA, Prieto VG et al. Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis. J Clin Pathol 2019; 72: 337–40.
- 16.
Amin MB, Edge S, Greene F et al. AJCC cancer staging manual. 8. utg. Chicago IL: American Joint Committee on Cancer, Springer, 2017.
- 17.
Perez MC, de Pinho FR, Holstein A et al. Resection margins in Merkel cell carcinoma: Is a 1-cm margin wide enough? Ann Surg Oncol 2018; 25: 3334–40. [PubMed][CrossRef]
- 18.
Andruska N, Fischer-Valuck BW, Mahapatra L et al. Association between surgical margins larger than 1 cm and overall survival in patients with Merkel cell carcinoma. JAMA Dermatol 2021; 157: 540–8. [PubMed][CrossRef]
- 19.
Lebbe C, Becker JC, Grob JJ et al. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer 2015; 51: 2396–403. [PubMed][CrossRef]
- 20.
Gunaratne DA, Howle JR, Veness MJ. Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases. Br J Dermatol 2016; 174: 273–81. [PubMed][CrossRef]
- 21.
Lee JS, Durham AB, Bichakjian CK et al. Completion lymph node dissection or radiation therapy for sentinel node metastasis in Merkel cell carcinoma. Ann Surg Oncol 2019; 26: 386–94. [PubMed][CrossRef]
- 22.
Fang LC, Lemos B, Douglas J et al. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma. Cancer 2010; 116: 1783–90. [PubMed][CrossRef]
- 23.
Patel SA, Qureshi MM, Sahni D et al. Identifying an optimal adjuvant radiotherapy dose for extremity and trunk Merkel cell carcinoma following resection: An analysis of the national cancer database. JAMA Dermatol 2017; 153: 1007–14. [PubMed][CrossRef]
- 24.
Nghiem P, Kaufman HL, Bharmal M et al. Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma. Future Oncol 2017; 13: 1263–79. [PubMed][CrossRef]
- 25.
D'Angelo SP, Bhatia S, Brohl AS et al. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial. J Immunother Cancer 2020; 8: e000674. [PubMed][CrossRef]
- 26.
Nghiem P, Bhatia S, Lipson EJ et al. Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy. J Clin Oncol 2019; 37: 693–702. [PubMed][CrossRef]
- 27.
Topalian SL, Bhatia S, Amin A et al. Neoadjuvant nivolumab for patients with resectable Merkel cell carcinoma in the Checkmate 358 trial. J Clin Oncol 2020; 38: 2476–87. [PubMed][CrossRef]
- 28.
Morley J, Grocott P, Purssell E et al. Electrochemotherapy for the palliative management of cutaneous metastases: A systematic review and meta-analysis. Eur J Surg Oncol 2019; 45: 2257–67. [PubMed][CrossRef]
- 29.
Spasojevic M, Mariathasan AB, Frich L et al. Kreftbehandling med isolert ekstremitetsperfusjon. Tidsskr Nor Legeforen 2021; 141: 1186–9.
- 30.
van Veenendaal LM, Madu MF, Tesselaar MET et al. Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience. Eur J Surg Oncol 2017; 43: 2157–62. [PubMed][CrossRef]
- 31.
Paulson KG, Lewis CW, Redman MW et al. Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study. Cancer 2017; 123: 1464–74. [PubMed][CrossRef]
- 32.
van Veenendaal LM, Bertolli E, Korse CM et al. The clinical utility of neuron-specific enolase (NSE) serum levels as a biomarker for Merkel cell carcinoma (MCC). Ann Surg Oncol 2021; 28: 1019–28. [PubMed][CrossRef]
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.